To address a donor-deferral listing, start with the blood or plasma center that reported the deferral. Ask for the reason, test type, dates, confirmatory results, and applicable requalification procedure. A later negative test does not automatically require immediate removal from every deferral system. [1]
Identify the actual reason
Temporary eligibility issues, repeatedly reactive screening results, confirmed infection, and a record error involve different rules. Ask whether the listing concerns an industry registry, the center’s internal records, or both. FDA regulates donor eligibility, but an individual cannot assume FDA directly deletes an industry database entry on request.
Requalification is test-specific
FDA has published reentry guidance for particular situations, including specified reactive hepatitis B core antibody results. Such a pathway has defined testing and timing requirements; it cannot be generalized to every infection or screening result. [2]
For example, evidence that one screening result was falsely reactive may support review under the applicable protocol. It is not equivalent to proving that all donor-eligibility requirements are satisfied.
Request a written explanation
Keep your test reports and correspondence. Ask the center’s medical or quality staff what evidence is required, who can authorize reentry, and how any confirmed record error is corrected. Seek clinical interpretation of medical results independently of donation eligibility.
Do not generalize a transfusion-donor protocol to every plasma case
A reentry guidance may address a defined group of blood donors and a specific testing pattern. Its availability does not itself establish that a commercial Source Plasma center must clear an NDDR entry under the same protocol. Ask the center to identify which eligibility rule and validated process it applies to the actual donation product and result. Also distinguish a database correction for misidentification from medical requalification after a genuine reactive result. A personal clinician can help interpret clinical evidence, while the collection establishment must satisfy its regulated eligibility process. Keep both decisions documented rather than treating a negative result from an unrelated test as a universal clearance certificate. [1] [2]
Before arranging more tests, ask the center what its written protocol actually requires. A clinician’s assessment of infection and a collection center’s donor-eligibility decision serve different purposes; keep both explanations rather than treating either as automatic clearance from every registry.
Primary sources
- 21 CFR 610.41 – Donor Deferral
- Requalification Method for Reentry of Blood Donors Deferred Because of Reactive Test Results for Antibody
Sources checked: October 31, 2026.